Celcuity (CELC) Interest & Investment Income (2016 - 2025)
Celcuity (CELC) reported Interest & Investment Income of $4.4 million for Q4 2025, up 43.97% on a YoY basis from $3.1 million in Q4 2024, and up 20.71% quarter-over-quarter from $3.6 million in Q3 2025.
Celcuity (CELC) Interest & Investment Income (2016 - 2025) Analysis & Trends
Celcuity has reported Interest & Investment Income for 10 years, with the latest figure at $4.4 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income rose 43.97% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2025 stood at $12.3 million (up 4.5% YoY), and the FY2025 full-year result was $12.3 million, up 4.5% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $4.4 million, up from $3.6 million in the prior quarter.
- The five-year high for Interest & Investment Income was $4.4 million in Q4 2025, with the low at $389.0 in Q1 2021.
- Historically, Interest & Investment Income has averaged $1.6 million across 5 years, with a median of $1.9 million in 2023.
- Annual changes were most pronounced in 2021 — Interest & Investment Income sank 99.39% — and 2023, when it jumped 22588.22%.
- Celcuity's Interest & Investment Income stood at $5459.0 in 2021, then jumped by 13379.78% to $735861.0 in 2022, then surged by 209.58% to $2.3 million in 2023, then soared by 33.97% to $3.1 million in 2024, then surged by 43.97% to $4.4 million in 2025.
- The last three Interest & Investment Income figures came in at $4.4 million (Q4 2025), $3.6 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 4.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.39 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 3.05 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 2.28 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 735,861.00 |
| Sep 30, 2022 | 287,495.00 |
| Jun 30, 2022 | 95,646.00 |
| Mar 31, 2022 | 8,159.00 |
| Dec 31, 2021 | 5,459.00 |
| Sep 30, 2021 | 5,612.00 |
| Jun 30, 2021 | 1,803.00 |
| Mar 31, 2021 | 389.00 |